(Dab9)-Neurotensin (8-13) is a neurotensin fragment with a D-aminobutyric acid (Dab) substitution at position 9 that modulates receptor affinity and peptide stability. The substitution helps to investigate receptor subtypes and their activation mechanisms. Researchers use it to explore neurotensin-mediated signaling and its involvement in neurotransmitter release and pain regulation.
CAT No: N05044
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More